We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
One of the federal investigations into a reverse-payment deal involving generic Plavix found no violations of federal securities laws on the part of Bristol-Myers Squibb (BMS), the company said.
Shire Laboratories’ plan to acquire a smaller specialty drug manufacturer, giving it full control of the marketing and manufacturing of the attention-deficit/hyperactivity disorder (ADHD) drug Vyvanse, could put it in the same market as generic Adderall XR, according to a company source.
Watson Pharmaceuticals has agreed to license its bupropion hydrochloride absorption method patent for $35 million as part of a settlement to resolve patent litigation regarding GlaxoSmithKline’s (GSK) Wellbutrin XL.
Starpharma signed a funding agreement this week with several federal agencies for further study of VivaGel, an HIV and genital herpes prevention drug, in sexually active women.
The FTC is set to approve a plan proposed by Hospira to acquire Australia-based generic firm Mayne Pharma for $2 billion, as long as certain conditions are met, the agency has announced.
The FTC is set to approve a plan proposed by Hospira to acquire Australia-based generic firm Mayne Pharma for $2 billion, as long as certain conditions are met, the agency has announced.